Postural Management of Hyperkyphosis in Cardiac Rehab Patients
1 other identifier
interventional
62
1 country
1
Brief Summary
The goal of this clinical trial is to evaluate the efficacy of a home-based exercise program in managing hyperkyphosis, and its impact on physical performance and pulmonary function among cardiac rehabilitation patients. The primary research question is: Can a home-based kyphosis-specific exercise program reduce thoracic hyperkyphosis and improve physical ability in cardiac patients undergoing cardiac rehabilitation? The study will consist of three groups: 1) Hyperkyphotic participants undergoing a 12-week exercise program at home, alongside a cardiac rehabilitation exercise program, 2) Hyperkyphotic participants solely undergoing cardiac rehabilitation exercise program, and 3) Participants without hyperkyphosis solely undergoing cardiac rehabilitation exercise program. The groups will be evaluated based on measurements of kyphosis index, physical performance and spirometry at the beginning, after 6 weeks, and upon completion of the 12-week program.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 21, 2024
CompletedFirst Submitted
Initial submission to the registry
May 4, 2024
CompletedFirst Posted
Study publicly available on registry
August 21, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 2, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
May 2, 2025
CompletedOctober 2, 2025
September 1, 2025
1 year
May 4, 2024
September 29, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Degree of Kyphosis
This measure will be obtained using a 60-centimeter flexicurve ruler, placed over the subject's back, from the C7 spinous process down to the T12 spinous process. Once attached to the back, the flexicurve molds according to its shape, allowing tracing of the thoracic curve onto paper. Maximum width and length measurements are then taken of the curve in centimeters in order to calculate the kyphosis index. Kyphosis index is calculated as the ratio of thoracic width to thoracic length. A higher index value indicates a greater degree of kyphosis, with values exceeding 13 considered hyperkyphosis. Assessment will occur at the program's start, after 6 weeks, and upon completion of the 12-week program.
Assessment will occur at baseline, after 6 weeks, and upon completion of the 12-week program.
Secondary Outcomes (11)
Maximum Metabolic Equivalents (METs)
The measurement will be taken at baseline and upon completion of the 12-week program.
Peak Heart Rate
The measurement will be taken at baseline and upon completion of the 12-week program.
Peak Systolic and Diastolic Blood Pressure
The measurement will be taken at baseline and upon completion of the 12-week program.
Distance covered in a six-minute walk test
The test will be conducted at baseline, after 6 weeks, and upon completion of the 12-week program.
Time to complete the Five Times Sit to Stand Test (FTSST)
The test will be conducted at baseline, after 6 weeks, and upon completion of the 12-week program.
- +6 more secondary outcomes
Study Arms (3)
Home-based exercise program
EXPERIMENTALIntervention Group: Hyperkyphotic participants will participate in a home exercise program designed to improve thoracic spine and shoulder mobility and flexibility, while also strengthening spine extensor muscles, alongside a cardiac rehabilitation exercise program. The home-based program will include six exercises to be performed three times a week over a period of 12 weeks.
Cardiac rehabilitation exercise program - Hyperkyphosis
OTHERControl Group: Hyperkyphotic participants will participate in a 12-week cardiac rehabilitation exercise program, consisting of two one-hour sessions per week at the cardiac rehabilitation center. These sessions will include aerobic activity along with a variety of resistance, flexibility, and balance exercises.
cardiac rehabilitation exercise program - without hyperkyphosis
OTHERControl Group: Participants without hyperkyphosis will participate in a 12-week cardiac rehabilitation exercise program, consisting of two one-hour sessions per week at the cardiac rehabilitation center. These sessions will include aerobic activity along with a variety of resistance, flexibility, and balance exercises.
Interventions
The program will comprise of six exercises aimed at improving the mobility of the thoracic spine and shoulders, strengthening the extensor muscles of the spine, and enhancing the flexibility of the chest and anterior shoulders. Progression within the program will involve increasing exercise duration or repetitions/sets, along with implementing postural corrections in compound exercises. Participants will be instructed to perform the exercises at least three times a week. To heighten participants awareness of their daily posture, they will receive a daily scheduled message via WhatsApp reminding them to focus on their posture. Once a week, participants will be asked to submit a home exercise tracking report to monitor their adherence to the program. Additionally, exercises execution will be reviewed every two weeks, and adjustments to the program will be made accordingly.
No intervention
Eligibility Criteria
You may qualify if:
- Heart patients who will be admitted for cardiac rehabilitation at Hadassah - Mount Scopus Hospital
- Normal stress test results.
- Independent mobility.
- Stable hemodynamic and respiratory status.
- Ability to speak and read basic Hebrew×¥
- Ability to watch videos on a mobile phone or computer.
- Not receiving any other forms of physical therapy or physical treatment.
You may not qualify if:
- Presence of unstable angina.
- Neurological disorders or mental illnesses that interfere with communication.
- Movement disorders due to neurological disease.
- Severe orthopedic limitations hindering the execution of motor exercises.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hadassah Medical Organization
Jerusalem, Israek, 91120, Israel
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 4, 2024
First Posted
August 21, 2024
Study Start
April 21, 2024
Primary Completion
May 2, 2025
Study Completion
May 2, 2025
Last Updated
October 2, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR